Resources from the same session
Introduction by the chair
Presenter: Elizabeth Smyth
Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer
Resources:
Slides
Webcast
Polling 1 (led by chair)
Presenter: All Speakers
Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer
Resources:
Slides
Webcast
Contra: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer
Presenter: Raghav Sundar
Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: All Speakers
Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer
Resources:
Slides
Webcast